首页> 外文会议>International Gastric Cancer Congress >Good results after D2 gastrectomy in western advanced N0 gastric cancer patients: a multicentric analysis
【24h】

Good results after D2 gastrectomy in western advanced N0 gastric cancer patients: a multicentric analysis

机译:西部晚期N0胃癌患者D2胃切除术后的良好结果:多中心分析

获取原文

摘要

The records of 301 patients who underwent curative gastrectomy for gastric carcinoma and were adequately staged as N0 between 1995 and 2002 were retrospectively analyzed, under the auspices of the Italian Study Group for Gastric Cancer. Disease specific and disease free survival after 3, 5 and 10 years were 90.4%, 86.1%, 75.9% and 72.1%, 57.3%, 57.3%. Thus, survival was similar to that previously reported by Eastern Centers. Mortality was 1.7%. The factors associated with a better disease-specific survival at univariate analysis were age<60, T2 tumors, distal location, intestinal histotype and number of retrieved nodes>25; depth of infiltration and histotype were the only 2 independent predictors of 5 year recurrence free survival at multivariate analysis. These parameters must be considered to stratify node-negative gastric cancer patients for an adjuvant treatment and for follow-up scheduling.
机译:回顾性地分析了1995年至2002年在1995年至2002年期间接受胃癌治疗胃癌患者的301例患者的记录,并在意大利研究组胃癌的主持下进行了回顾性。疾病特异性和无疾病的生存率3,5和10岁以90.4%,86.1%,75.9%和72.1%,57.3%,57.3%。因此,生存类似于东方中心先前报道的。死亡率为1.7%。在单变量分析中与更好的疾病特异性存活相关的因素是年龄<60,T2肿瘤,远端位置,肠型和检索节点的数量> 25;渗透和组织型的深度是多元分析中的5年复发存活的唯一2个独立预测因子。必须考虑这些参数来分层节点阴性胃癌患者进行佐剂治疗和随访调度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号